Increased matrix metalloproteinase-9 in the airway after allergen challenge.
暂无分享,去创建一个
[1] T. Sorsa,et al. MMP-9 as a marker of inflammation in tracheal epithelial lining fluid (TELF) and in bronchoalveolar fluid (BALF) of COPD horses. , 2010, Equine veterinary journal.
[2] T. Salo,et al. In vivo collagenase‐2 (MMP‐8) expression by human bronchial epithelial cells and monocytes/macrophages in bronchiectasis , 2001, The Journal of pathology.
[3] K. Chung,et al. Neutrophilic inflammation in severe persistent asthma. , 1999, American journal of respiratory and critical care medicine.
[4] J. Bousquet,et al. Tissue inhibitor of metalloproteinase-1 levels in bronchoalveolar lavage fluid from asthmatic subjects. , 1999, American journal of respiratory and critical care medicine.
[5] T. Out,et al. Influx of Neutrophils into the Airway Lumen at 4 h after Segmental Allergen Challenge in Asthma , 1999, International Archives of Allergy and Immunology.
[6] D. Hartmann,et al. Contribution of 92 kDa gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus. , 1999, American journal of respiratory and critical care medicine.
[7] K. Shirato,et al. Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma. , 1999, Journal of immunology.
[8] W. Busse,et al. Segmental antigen challenge increases fibronectin in bronchoalveolar lavage fluid. , 1999, American journal of respiratory and critical care medicine.
[9] L. Boulet,et al. Serum matrix metalloproteinase-9:Tissue inhibitor of metalloproteinase-1 ratio correlates with steroid responsiveness in moderate to severe asthma. , 1999, American journal of respiratory and critical care medicine.
[10] J. Bousquet,et al. Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. , 1998, American journal of respiratory and critical care medicine.
[11] S. Isogai,et al. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. , 1998, The Journal of allergy and clinical immunology.
[12] F. Saulnier,et al. Bronchial neutrophilia in patients with noninfectious status asthmaticus. , 1998, American journal of respiratory and critical care medicine.
[13] J. Bousquet,et al. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. , 1997, American journal of respiratory cell and molecular biology.
[14] H. Kita,et al. Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. , 1997, American journal of respiratory cell and molecular biology.
[15] S. Wenzel,et al. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. , 1997, American journal of respiratory and critical care medicine.
[16] U. Bergmann,et al. Activation of Type IV Procollagenases by Human Tumor-associated Trypsin-2* , 1997, The Journal of Biological Chemistry.
[17] W. Luttmann,et al. Matrix metalloproteinases in bronchoalveolar lavage fluid following antigen challenge. , 1997, International archives of allergy and immunology.
[18] K. Shirato,et al. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. , 1997, American journal of respiratory cell and molecular biology.
[19] S. Holgate. Asthma: a dynamic disease of inflammation and repair. , 1997, Ciba Foundation symposium.
[20] H. Kolkenbrock,et al. Progelatinase B forms from human neutrophils. complex formation of monomer/lipocalin with TIMP-1. , 1996, Biological chemistry.
[21] C. Delacourt,et al. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. , 1996, American journal of respiratory cell and molecular biology.
[22] E. Waubant,et al. T cell gelatinases mediate basement membrane transmigration in vitro. , 1995, Journal of immunology.
[23] P. Howarth,et al. Neutrophil influx and interleukin-8 release after segmental allergen or saline challenge in asthmatics. , 1995, International archives of allergy and immunology.
[24] Woessner Jf. Quantification of matrix metalloproteinases in tissue samples. , 1995 .
[25] W. Parks,et al. 92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen. , 1994, The Journal of clinical investigation.
[26] W. Busse,et al. Mechanism of airway inflammation in asthma. , 1993, The American review of respiratory disease.
[27] W. Busse,et al. Increased airway inflammation with segmental versus aerosol antigen challenge. , 1993, The American review of respiratory disease.
[28] J. Bousquet,et al. Asthma: a disease remodeling the airways , 1992, Allergy.
[29] S. Weiss. Tissue destruction by neutrophils. , 1989, The New England journal of medicine.
[30] S. Spector,et al. Standardization of bronchial inhalation challenge procedures. , 1975, The Journal of allergy and clinical immunology.
[31] I. W. Mclean,et al. PERIODATE-LYSINE-PARAFORMALDEHYDE FIXATIVE A NEW FIXATIVE FOR IMMUNOELECTRON MICROSCOPY , 1974, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.